The point is that VLA have the patent which covers the right to use EVATAKTM (The trademarked name of Viralytics proprietary formulation of the Echovirus Type 1) in conjunction with other oncolytic virusessuch as the Companys lead product CAVATAKTM.
- Forums
- ASX - By Stock
- VLA
- i think this one a little different...
i think this one a little different..., page-23
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)